Nxera Pharma (SOLTF) Short Interest Ratio & Short Volume $6.20 -0.40 (-6.06%) As of 09:30 AM Eastern Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesShort InterestBuy This Stock Nxera Pharma Short Interest DataNxera Pharma (SOLTF) has a short interest of 1.82 million shares. This marks a 5.89% increase in short interest from the previous month. The short interest ratio (days to cover) is 18,241.0, indicating that it would take 18,241.0 days of the average trading volume of 688 shares to cover all short positions.Current Short Interest1,824,100 sharesPrevious Short Interest1,722,700 sharesChange Vs. Previous Month+5.89%Dollar Volume Sold Short$12.77 millionShort Interest Ratio18,241.0 Days to CoverLast Record DateJune 15, 2025Today's Trading Volume1,600 sharesAverage Trading Volume688 sharesToday's Volume Vs. Average233% Short Selling Nxera Pharma? Sign up to receive the latest short interest report for Nxera Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSOLTF Short Interest Over TimeSOLTF Days to Cover Over TimeSOLTF Percentage of Float Shorted Over Time Nxera Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/20251,824,100 shares $12.77 million +5.9%N/A18241 $7.00 5/31/20251,722,700 shares $10.18 million -4.8%N/A5742.3 $5.91 5/15/20251,809,400 shares $10.69 million +0.5%N/A0 $5.91 4/30/20251,800,200 shares $10.64 million +3.7%N/A0 $5.91 4/15/20251,735,800 shares $10.26 million +0.0%N/A0 $5.91 3/31/20251,735,300 shares $10.26 million -5.6%N/A17353 $5.91 3/15/20251,838,500 shares $11.99 million +1.6%N/A0 $6.52 2/28/20251,809,600 shares $11.80 million -3.3%N/A0 $6.52 2/15/20251,872,000 shares $12.21 million -5.3%N/A0 $6.52 1/31/20251,976,200 shares $12.88 million +3.2%N/A9881 $6.52 Get the Latest News and Ratings for SOLTF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nxera Pharma and its competitors with MarketBeat's FREE daily newsletter. 1/15/20251,915,600 shares $12.49 million +4.8%N/A19156 $6.52 12/31/20241,827,100 shares $11.25 million -7.1%N/A1661 $6.16 12/15/20241,966,400 shares $13.67 million +1.8%N/A3932.8 $6.95 11/30/20241,931,300 shares $15.55 million +0.7%N/A0 $8.05 11/15/20241,917,800 shares $15.44 million -1.5%N/A19178 $8.05 10/31/20241,947,800 shares $14.12 million -3.5%N/A1947.8 $7.25 10/15/20242,018,600 shares $18.21 million +7.0%N/A20186 $9.02 9/30/20241,887,500 shares $17.27 million -5.9%N/A18875 $9.15 9/15/20242,006,700 shares $16.50 million -16.6%N/A20067 $8.22 8/31/20242,405,300 shares $22.73 million +2.0%N/A24053 $9.45 8/15/20242,359,000 shares $22.32 million +3.5%N/A23590 $9.46 7/31/20242,278,700 shares $24.00 million -7.0%N/A22787 $10.53 7/15/20242,450,700 shares $25.09 million +3.4%N/A24507 $10.24 6/30/20242,370,400 shares $22.35 million +0.2%N/A23704 $9.43 6/15/20242,365,000 shares $23.65 million +7.5%N/A11824.9 $10.00 5/31/20242,200,500 shares $19.52 million -9.1%N/A7335 $8.87 5/15/20242,419,800 shares $23.71 million -1.6%N/A12099 $9.80 4/30/20242,460,000 shares $22.89 million +13.1%N/A8200 $9.30 4/15/20242,175,400 shares $22.71 million +8.9%N/A7251.3 $10.44 3/31/20241,996,800 shares $21.02 million -7.4%N/A19968 $10.53 3/15/20242,156,300 shares $23.17 million -5.0%N/A287.5 $10.75 2/29/20242,269,300 shares $19.79 million +13.2%N/A22693 $8.72 2/15/20242,004,900 shares $17.34 million +22.3%N/A5012.3 $8.65 1/15/20241,294,200 shares $14.09 million -1.2%N/A2157 $10.89 12/31/20231,309,700 shares $13.10 million +8.2%N/A1437.6 $10.00 12/15/20231,211,000 shares $12.09 million -9.0%N/A2422 $9.98 11/30/20231,330,900 shares $13.24 million +25.3%N/A3327.3 $9.95 11/15/20231,062,100 shares $10.38 million -29.0%N/A5310.5 $9.77 10/31/20231,495,200 shares $13.35 million -6.8%N/A4984 $8.93 10/15/20231,603,600 shares $15.91 million -1.7%N/A1781.8 $9.92The $7 company helping Nvidia build the world’s first trillion-dollar robot … (Ad)Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains.Now he's identified his next potential winner. Click here to find out more. 9/30/20231,631,100 shares $16.64 million -6.0%N/A1812.3 $10.20 9/15/20231,735,300 shares $18.48 million -0.5%N/A2169.1 $10.65 8/31/20231,743,600 shares $20.26 million -0.8%N/A1748.9 $11.62 8/15/20231,757,400 shares $21.09 million -17.2%N/A5858 $12.00 7/31/20232,121,800 shares $27.48 million +52.4%N/A5304.5 $12.95 7/15/20231,392,500 shares $15.08 million +8.6%N/A633 $10.83 6/30/20231,281,900 shares $13.46 million -15.3%N/A145.7 $10.50 6/15/20231,513,300 shares $32.28 million -31.4%N/A1513.3 $21.33 5/31/20232,204,300 shares $49.37 million +6.7%N/A4408.6 $22.40 5/15/20232,065,500 shares $43.54 million +13.8%N/A10327.5 $21.08 4/30/20231,815,800 shares $35.92 million +19.7%N/A1513.2 $19.78 4/15/20231,516,400 shares $30.72 million +13.3%N/A3791 $20.26 3/31/20231,338,100 shares $22.68 million +3.1%N/A418.2 $16.95 3/15/20231,297,400 shares $23.56 million +19.7%N/A158.2 $18.16 2/28/20231,083,900 shares $17.61 million +1.3%N/A142.6 $16.25 2/15/20231,069,700 shares $16.63 million -5.1%N/A10697 $15.54 1/31/20231,127,500 shares $17.53 million +14.3%N/A0 $15.54 1/15/2023986,700 shares $15.34 million +27.9%N/A4933.5 $15.54 12/30/2022771,500 shares $11.99 million +1.2%N/A7715 $15.54 12/15/2022762,600 shares $8.66 million -14.9%N/A0 $11.36 11/30/2022896,200 shares $10.18 million -18.0%N/A0 $11.36 11/15/20221,093,100 shares $12.42 million -7.4%N/A0 $11.36 10/31/20221,180,100 shares $13.41 million -9.7%N/A0 $11.36 10/15/20221,306,300 shares $14.84 million -3.8%N/A0 $11.36 9/30/20221,357,200 shares $15.42 million +0.8%N/A0 $11.36 9/15/20221,346,500 shares $15.30 million -3.7%N/A0 $11.36 8/31/20221,397,800 shares $15.88 million +32.3%N/A6989 $11.36 8/15/20221,056,200 shares $13.04 million +5.9%N/A3520.7 $12.35 7/31/2022997,700 shares $8.42 million -2.6%N/A0 $8.44 7/15/20221,024,600 shares $8.65 million -24.0%N/A0 $8.44 6/30/20221,347,300 shares $11.37 million -1.9%N/A0 $8.44 6/15/20221,373,200 shares $11.59 million -7.6%N/A0 $8.44 5/31/20221,485,500 shares $12.54 million -1.9%N/A0 $8.44 5/15/20221,514,900 shares $12.79 million -0.5%N/A15149 $8.44 4/30/20221,521,700 shares $19.60 million -3.5%N/A0 $12.88 4/15/20221,577,200 shares $20.31 million +0.9%N/A0 $12.88 3/31/20221,563,500 shares $20.14 million +7.6%N/A0 $12.88 3/15/20221,453,100 shares $18.72 million -3.3%N/A14531 $12.88 2/28/20221,502,400 shares $19.19 million -23.8%N/A0 $12.77 2/15/20221,970,800 shares $25.17 million -10.2%N/A0 $12.77 1/31/20222,193,500 shares $28.01 million -12.0%N/A10967.5 $12.77 1/15/20222,491,300 shares $42.53 million +9.2%N/A0 $17.07 12/31/20212,280,600 shares $38.93 million +6.2%N/A22806 $17.07 12/15/20212,148,000 shares $40.00 million +2.3%N/A0 $18.62 11/30/20212,100,300 shares $44.13 million +35.8%N/A21003 $21.01 11/15/20211,546,400 shares $23.86 million +1.5%N/A7732 $15.43 10/29/20211,523,900 shares $26.94 million -0.3%N/A0 $17.68 10/15/20211,529,100 shares $27.03 million +12.6%N/A0 $17.68 9/30/20211,358,400 shares $24.65 million -7.5%N/A13584 $18.15 9/15/20211,467,700 shares $23.97 million +0.5%N/A0 $16.33The $7 company helping Nvidia build the world’s first trillion-dollar robot … (Ad)Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains.Now he's identified his next potential winner. Click here to find out more. 8/31/20211,459,800 shares $23.84 million +3.2%N/A0 $16.33 8/13/20211,414,500 shares $23.10 million -2.0%N/A0 $16.33 7/30/20211,443,400 shares $23.57 million -0.1%N/A0 $16.33 7/15/20211,444,200 shares $23.58 million +22.3%N/A7221 $16.33 6/30/20211,180,500 shares $19.28 million +8.7%N/A11805 $16.33 6/15/20211,085,800 shares $14.40 million +13.5%N/A0 $13.26 5/28/2021956,600 shares $12.68 million +1.4%N/A1594.3 $13.26 5/14/2021943,100 shares $15.61 million +2.2%N/A0 $16.55 4/30/2021922,600 shares $15.27 million -0.3%N/A0 $16.55 4/15/2021925,400 shares $15.32 million -11.0%N/A0 $16.55 3/31/20211,039,500 shares $17.20 million -10.2%N/A0 $16.55 3/15/20211,157,500 shares $19.16 million -22.9%N/A11575 $16.55 2/26/20211,500,700 shares $24.45 million -17.1%N/A0 $16.29 2/12/20211,810,000 shares $29.48 million -7.4%N/A0 $16.29 1/29/20211,954,800 shares $31.84 million +9.6%N/A0 $16.29 1/15/20211,605,500 shares $26.15 million -6.0%N/A16055 $16.29 12/31/20201,712,600 shares $27.04 million +6.7%N/A0 $15.79 12/15/20201,605,500 shares $25.35 million -6.0%N/A16055 $15.79 11/30/20201,708,300 shares $25.45 million +17.1%N/A0 $14.90 11/15/20201,458,900 shares $20.05 million -6.4%N/A14589 $13.74 10/30/20201,557,900 shares $17.39 million +12.0%N/A7789.5 $11.16 10/15/20201,391,000 shares $17.62 million +3.0%N/A0 $12.67 9/30/20201,351,200 shares $17.12 million +5.0%N/A6756 $12.67 9/15/20201,287,400 shares $17.23 million +7.0%N/A1839.1 $13.38 8/31/20201,202,800 shares $16.48 million +18.8%N/A0 $13.70 8/14/20201,012,700 shares $13.87 million -4.2%N/A10127 $13.70 7/31/20201,056,500 shares $15.27 million +0.7%N/A1760.8 $14.45 7/15/20201,048,800 shares $16.79 million +48.3%N/A0 $16.01 SOLTF Short Interest - Frequently Asked Questions What is Nxera Pharma's current short interest? Short interest is the volume of Nxera Pharma shares that have been sold short but have not yet been covered or closed out. As of June 15th, investors have sold 1,824,100 shares of SOLTF short. Learn More on Nxera Pharma's current short interest. What is a good short interest ratio for Nxera Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SOLTF shares currently have a short interest ratio of 18,241.0. Learn More on Nxera Pharma's short interest ratio. Is Nxera Pharma's short interest increasing or decreasing? Nxera Pharma saw a increase in short interest during the month of June. As of June 15th, there was short interest totaling 1,824,100 shares, an increase of 5.9% from the previous total of 1,722,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Nxera Pharma stock? Short selling SOLTF is an investing strategy that aims to generate trading profit from Nxera Pharma as its price is falling. SOLTF shares are trading down $0.40 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Nxera Pharma? A short squeeze for Nxera Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SOLTF, which in turn drives the price of the stock up even further. How often is Nxera Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SOLTF, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies TRSBF Short Interest Data AGNPF Short Interest Data AKBLF Short Interest Data APLMW Short Interest Data ASPHF Short Interest Data ASCLF Short Interest Data AVCTF Short Interest Data AWKNF Short Interest Data AXIM Short Interest Data BCTXW Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:SOLTF) was last updated on 7/10/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredHow a Kansas farm boy gained 1,285% in two daysA former farm kid placed a simple trade… and cashed out a 1,285% gain two days later. It wasn’t crypto or a...TradeSmith | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nxera Pharma Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nxera Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
